Literature DB >> 19723403

Sensitivity and specificity of fluorescence microscopy for diagnosing pulmonary tuberculosis in a high HIV prevalence setting.

A Cattamanchi1, J L Davis, W Worodria, S den Boon, S Yoo, J Matovu, J Kiidha, F Nankya, R Kyeyune, P Byanyima, A Andama, M Joloba, D H Osmond, P C Hopewell, L Huang.   

Abstract

SETTING: Mulago Hospital, Kampala, Uganda.
OBJECTIVE: To evaluate the diagnostic performance of fluorescence microscopy (FM) for diagnosing pulmonary tuberculosis (TB) in a high human immunodeficiency virus (HIV) prevalence setting.
DESIGN: Consecutive in-patients with cough for >2 weeks submitted two sputum specimens for smear microscopy. Smears were examined by conventional light microscopy (CM) and FM. The performance of the two methods was compared using mycobacterial culture as a reference standard.
RESULTS: A total of 426 patients (82% HIV-infected) were evaluated. FM identified 11% more smear-positive patients than CM (49% vs. 38%, P < 0.001). However, positive FM results were less likely than positive CM results to be confirmed by culture when smears were read as either 'scanty' (54% vs. 90%, P < 0.001) or 1+ (82% vs. 91%, P = 0.02). Compared to CM, the sensitivity of FM was higher (72% vs. 64%, P = 0.005), and the specificity lower (81% vs. 96%, P < 0.001). In receiver operating characteristic analysis, maximum area under the curve for FM was obtained at a threshold of >4 acid-fast bacilli/100 fields (sensitivity 68%, specificity 90%).
CONCLUSION: Although FM increases the sensitivity of sputum smear microscopy, additional data on FM specificity and on the clinical consequences associated with false-positive FM results are needed to guide implementation of this technology in high HIV prevalence settings.

Entities:  

Mesh:

Year:  2009        PMID: 19723403      PMCID: PMC2754584     

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  15 in total

1.  Empirical evidence of design-related bias in studies of diagnostic tests.

Authors:  J G Lijmer; B W Mol; S Heisterkamp; G J Bonsel; M H Prins; J H van der Meulen; P M Bossuyt
Journal:  JAMA       Date:  1999-09-15       Impact factor: 56.272

2.  Optimal tuberculosis case detection by direct sputum smear microscopy: how much better is more?

Authors:  A Van Deun; A Hamid Salim; E Cooreman; Md Anwar Hossain; A Rema; N Chambugonj; Md A Hye; A Kawria; E Declercq
Journal:  Int J Tuberc Lung Dis       Date:  2002-03       Impact factor: 2.373

3.  The STARD initiative.

Authors:  Patrick M Bossuyt; Johannes B Reitsma
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

4.  Tuberculosis diagnostics trials: do they lack methodological rigor?

Authors:  Madhukar Pai; Richard O'Brien
Journal:  Expert Rev Mol Diagn       Date:  2006-07       Impact factor: 5.225

5.  High sensitivity and specificity of acid-fast microscopy for diagnosis of pulmonary tuberculosis in an African population with a high prevalence of human immunodeficiency virus.

Authors:  Yvonne R Shea; J Lucian Davis; Laurence Huang; Joseph A Kovacs; Henry Masur; Francis Mulindwa; Sally Opus; Yuenwah Chow; Patrick R Murray
Journal:  J Clin Microbiol       Date:  2009-03-18       Impact factor: 5.948

6.  Comparison of the BACTEC MGIT 960 with Löwenstein-Jensen medium for recovery of mycobacteria from clinical specimens.

Authors:  H P Chien; M C Yu; M H Wu; T P Lin; K T Luh
Journal:  Int J Tuberc Lung Dis       Date:  2000-09       Impact factor: 2.373

7.  Efficacy of fluorochrome stain in the diagnosis of pulmonary tuberculosis co-infected with HIV.

Authors:  K Prasanthi; A R Kumari
Journal:  Indian J Med Microbiol       Date:  2005-07       Impact factor: 0.985

8.  A comprehensive comparison of Ziehl-Neelsen and fluorescence microscopy for the diagnosis of tuberculosis in a resource-poor urban setting.

Authors:  L E A Kivihya-Ndugga; M R A van Cleeff; W A Githui; L W Nganga; D K Kibuga; J A Odhiambo; Paul R Klatser
Journal:  Int J Tuberc Lung Dis       Date:  2003-12       Impact factor: 2.373

9.  Differences between clinical trials and postmarketing use.

Authors:  Karin Martin; Bernard Bégaud; Philippe Latry; Ghada Miremont-Salamé; Annie Fourrier; Nicholas Moore
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

Review 10.  Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative.

Authors:  Patrick M Bossuyt; Johannes B Reitsma; David E Bruns; Constantine A Gatsonis; Paul P Glasziou; Les M Irwig; Jeroen G Lijmer; David Moher; Drummond Rennie; Henrica C W de Vet
Journal:  Ann Intern Med       Date:  2003-01-07       Impact factor: 25.391

View more
  32 in total

1.  New diagnostics for tuberculosis: fulfilling patient needs first.

Authors:  Jean-François Lemaire; Martina Casenghi
Journal:  J Int AIDS Soc       Date:  2010-10-25       Impact factor: 5.396

2.  Bronchoscopy is useful for diagnosing smear-negative tuberculosis in HIV-infected patients.

Authors:  W Worodria; J L Davis; A Cattamanchi; A Andama; S den Boon; S D Yoo; P C Hopewell; L Huang
Journal:  Eur Respir J       Date:  2010-08       Impact factor: 16.671

3.  Increased sensitivity in diagnosis of tuberculosis in HIV-positive patients through the small-membrane-filter method of microscopy.

Authors:  Patrícia Quincó; Samira Bührer-Sékula; Walber Brandão; Rossiclea Monte; Silvia Leopoldina Souza; Valeria Saraceni; Moises Palaci; Reynaldo Dietze; Marcelo Cordeiro-Santos
Journal:  J Clin Microbiol       Date:  2013-06-26       Impact factor: 5.948

4.  Integrated strategies to optimize sputum smear microscopy: a prospective observational study.

Authors:  Adithya Cattamanchi; Laurence Huang; William Worodria; Saskia den Boon; Nelson Kalema; Winceslaus Katagira; Patrick Byanyima; Samuel Yoo; John Matovu; Philip C Hopewell; J Lucian Davis
Journal:  Am J Respir Crit Care Med       Date:  2010-09-17       Impact factor: 21.405

5.  Chest radiographic findings of pulmonary tuberculosis in severely immunocompromised patients with the human immunodeficiency virus.

Authors:  H N Kisembo; S Den Boon; J L Davis; R Okello; W Worodria; A Cattamanchi; L Huang; M G Kawooya
Journal:  Br J Radiol       Date:  2011-10-05       Impact factor: 3.039

6.  Causes of early mortality in HIV-infected TB suspects in an East African referral hospital.

Authors:  Rachel Kyeyune; Saskia den Boon; Adithya Cattamanchi; J Lucian Davis; William Worodria; Samuel D Yoo; Laurence Huang
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

7.  Procalcitonin predicts mortality in HIV-infected Ugandan adults with lower respiratory tract infections.

Authors:  Sofya Tokman; Christopher F Barnett; Leah G Jarlsberg; Pam R Taub; Saskia den Boon; J Lucian Davis; Adithya Cattamanchi; William Worodria; Alan Maisel; Laurence Huang
Journal:  Respirology       Date:  2014-01-26       Impact factor: 6.424

8.  Clinical and radiographic factors do not accurately diagnose smear-negative tuberculosis in HIV-infected inpatients in Uganda: a cross-sectional study.

Authors:  J Lucian Davis; William Worodria; Harriet Kisembo; John Z Metcalfe; Adithya Cattamanchi; Michael Kawooya; Rachel Kyeyune; Saskia den Boon; Krista Powell; Richard Okello; Samuel Yoo; Laurence Huang
Journal:  PLoS One       Date:  2010-03-26       Impact factor: 3.240

9.  Automated tuberculosis diagnosis using fluorescence images from a mobile microscope.

Authors:  Jeannette Chang; Pablo Arbeláez; Neil Switz; Clay Reber; Asa Tapley; J Lucian Davis; Adithya Cattamanchi; Daniel Fletcher; Jitendra Malik
Journal:  Med Image Comput Comput Assist Interv       Date:  2012

10.  Mobile digital fluorescence microscopy for diagnosis of tuberculosis.

Authors:  Asa Tapley; Neil Switz; Clay Reber; J Lucian Davis; Cecily Miller; John Baptist Matovu; William Worodria; Laurence Huang; Daniel A Fletcher; Adithya Cattamanchi
Journal:  J Clin Microbiol       Date:  2013-04-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.